ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Shionogi to leverage Ping An health care data to speed growth

Japanese pharma eyes Shanghai and Hong Kong JVs as fast-track to novel drugs

The Ping An Good Doctor online medical consultation app is used by 346 million people in China. (Photo by Naoki Matsuda)

OSAKA -- Japanese pharma Shionogi hopes two joint ventures with China's Ping An Insurance Group -- one already set up in Hong Kong and the other pending in Shanghai -- will be able to leverage its partner's huge health care database to design new drugs and services.

Shionogi and Ping An signed a capital and operational tie-up in March. The two joint ventures will aim to develop new drugs based on a database of over 300 million people maintained by Ping An.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more